NASDAQ:SMLR Semler Scientific (SMLR) Stock Price, News & Analysis → Gold Set to EXPLODE! (From Gold Safe Exchange) (Ad) Free SMLR Stock Alerts $22.96 +1.93 (+9.18%) (As of 05/9/2024 ET) Add Compare Share Share Today's Range$21.03▼$23.2850-Day Range$21.03▼$48.8552-Week Range$20.88▼$53.38Volume200,394 shsAverage Volume76,396 shsMarket Capitalization$161.41 millionP/E Ratio8.70Dividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Get Semler Scientific alerts: Email Address Ad Crypto 101 MediaThe Crypto 9-5 Escape PlanA brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.Click here to get instant access to the guide About Semler Scientific Stock (NASDAQ:SMLR)Semler Scientific, Inc. provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. It also offers Insulin Insights, a software program that is used by a healthcare provider to optimize outpatient insulin dosing. The company's products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, family practitioners, healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups and retailers. It offers its products through sales representatives and distributors. The company was incorporated in 2007 and is headquartered in Santa Clara, California.Read More SMLR Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SMLR Stock News HeadlinesMay 9, 2024 | finance.yahoo.comSemler Scientific First Quarter 2024 Earnings: Misses ExpectationsMay 8, 2024 | marketwatch.comSemler Scientific Shares Hit 52-Week Low After 1Q Earnings MissMay 10, 2024 | Unstoppable Prosperity (Ad)“Crash Insurance” For Your RetirementWhen it comes to retirement, everyone fears one thing… Outliving their retirement savings. You'll discover conservative, beginner-friendly options strategies which could help to cash flow your stock portfolio. May 8, 2024 | seekingalpha.comSemler Scientific: Great Product Can Still Thrive Post Medicare AdvantageMay 8, 2024 | finance.yahoo.comSemler Scientific, Inc. (NASDAQ:SMLR) Q1 2024 Earnings Call TranscriptMay 7, 2024 | msn.comSMLR Stock Earnings: Semler Scientific Misses EPS, Misses Revenue for Q1 2024May 7, 2024 | finance.yahoo.comSemler Scientific Inc (SMLR) Q1 Earnings: Mixed Results Amid Revenue Decline and Net Income GrowthMay 7, 2024 | prnewswire.comSemler Scientific® Reports First Quarter 2024 Financial ResultsMay 10, 2024 | Unstoppable Prosperity (Ad)“Crash Insurance” For Your RetirementWhen it comes to retirement, everyone fears one thing… Outliving their retirement savings. You'll discover conservative, beginner-friendly options strategies which could help to cash flow your stock portfolio. May 5, 2024 | americanbankingnews.comSemler Scientific (SMLR) Set to Announce Quarterly Earnings on TuesdayMay 1, 2024 | seekingalpha.comSemler Scientific: Not Perfect But Worth ConsideringApril 30, 2024 | finance.yahoo.comSemler Scientific, Inc. (NASDAQ:SMLR) is largely controlled by institutional shareholders who own 52% of the companyApril 28, 2024 | msn.com‘What a great town’: Dean Semler talks about growing up in RenmarkApril 28, 2024 | msn.comDean Semler’s Oscar win ‘meant so much’ to fellow AustraliansApril 28, 2024 | msn.com‘Best experience of my life’: Dean Semler on working with Mel Gibson on ApocalyptoApril 23, 2024 | finance.yahoo.comSemler Scientific to Report First Quarter Financial Results and Host Conference Call on May 7, 2024April 9, 2024 | finance.yahoo.comSemler Scientific (NASDAQ:SMLR) investors are sitting on a loss of 74% if they invested three years agoMarch 27, 2024 | investorplace.comThe Healthcare Bargain Blitz: 7 Undervalued Stocks to Inject into Your PortfolioMarch 23, 2024 | wsj.comSemler Scientific Inc.March 7, 2024 | finance.yahoo.comSemler Scientific Inc (SMLR) Reports Robust Revenue and Net Income Growth in Q4 and Full Year 2023March 7, 2024 | finance.yahoo.comSemler Scientific, Inc. (NASDAQ:SMLR) Q4 2023 Earnings Call TranscriptMarch 7, 2024 | seekingalpha.comSemler Scientific, Inc. (SMLR) Q4 2023 Earnings Call TranscriptMarch 6, 2024 | finance.yahoo.comSemler Scientific Reports Fourth Quarter and Full Year 2023 Financial ResultsMarch 4, 2024 | benzinga.comSemler Scientific's Earnings: A PreviewFebruary 28, 2024 | finance.yahoo.comSemler Scientific, Inc. (SMLR)February 21, 2024 | finance.yahoo.comSemler Scientific to Report Fourth Quarter and Year End 2023 Financial Results and Host Conference Call on March 5, 2024February 21, 2024 | prnewswire.comSemler Scientific to Report Fourth Quarter and Year End 2023 Financial Results and Host Conference Call on March 5, 2024See More Headlines Receive SMLR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Semler Scientific and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/05/2024Today5/09/2024Next Earnings (Estimated)8/08/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Electromedical equipment Sub-IndustryN/A Current SymbolNASDAQ:SMLR CUSIPN/A CIK1554859 Webwww.semlerscientific.com Phone877-774-4211FaxN/AEmployees92Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)$2.64 Trailing P/E Ratio8.70 Forward P/E RatioN/A P/E GrowthN/ANet Income$20.58 million Net Margins30.19% Pretax Margin35.35% Return on Equity30.60% Return on Assets27.15% Debt Debt-to-Equity RatioN/A Current Ratio10.64 Quick Ratio10.56 Sales & Book Value Annual Sales$68.18 million Price / Sales2.37 Cash Flow$2.62 per share Price / Cash Flow8.76 Book Value$10.45 per share Price / Book2.20Miscellaneous Outstanding Shares7,030,000Free Float4,922,000Market Cap$161.41 million OptionableNot Optionable Beta0.92 7 Energy Stocks to Buy and Hold ForeverDo you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.Get This Free Report Key ExecutivesMs. Renae Cormier (Age 51)CFO, Principal Accounting Officer, Head of Corp. Communications & Bus. Strategy and Secretary Comp: $374.71kDr. Douglas Murphy-Chutorian M.D. (Age 70)CEO, President & Director Comp: $870.46kDr. Herbert J. Semler (Age 96)Founder & Chairman Emeritus Comp: $41.25kMs. Jennifer Oliva HerringtonChief Operating OfficerMr. Shane ReidChief Technology OfficerMs. Cindy GuinassoSenior Vice President of Business DevelopmentMore ExecutivesKey CompetitorsOutset MedicalNASDAQ:OMElectromedNYSE:ELMDAxoGenNASDAQ:AXGNEdap TmsNASDAQ:EDAPFONARNASDAQ:FONRView All CompetitorsInsiders & InstitutionsHorizon Investment Services LLCBought 2,203 shares on 5/7/2024Ownership: 0.119%LSV Asset ManagementBought 92,851 shares on 5/6/2024Ownership: 3.597%Greenwood Capital Associates LLCBought 6,036 shares on 5/2/2024Ownership: 0.311%Janney Montgomery Scott LLCBought 23,962 shares on 5/1/2024Ownership: 0.341%Pinnacle Associates Ltd.Sold 2,720 shares on 4/26/2024Ownership: 0.379%View All Insider TransactionsView All Institutional Transactions SMLR Stock Analysis - Frequently Asked Questions How have SMLR shares performed in 2024? Semler Scientific's stock was trading at $44.29 at the beginning of 2024. Since then, SMLR shares have decreased by 48.2% and is now trading at $22.96. View the best growth stocks for 2024 here. When is Semler Scientific's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, August 8th 2024. View our SMLR earnings forecast. How were Semler Scientific's earnings last quarter? Semler Scientific, Inc. (NASDAQ:SMLR) issued its quarterly earnings data on Tuesday, March, 5th. The company reported $0.55 EPS for the quarter. The company had revenue of $15.06 million for the quarter. Semler Scientific had a trailing twelve-month return on equity of 30.60% and a net margin of 30.19%. Who are Semler Scientific's major shareholders? Semler Scientific's stock is owned by a number of retail and institutional investors. Top institutional investors include LSV Asset Management (3.60%), Pinnacle Associates Ltd. (0.38%), Allspring Global Investments Holdings LLC (0.37%), Janney Montgomery Scott LLC (0.34%), Greenwood Capital Associates LLC (0.31%) and Horizon Investment Services LLC (0.12%). Insiders that own company stock include Douglas Murphy-Chutorian, Eric Semler, HC Chang & Diana Sho William and Wayne T Pan. View institutional ownership trends. How do I buy shares of Semler Scientific? Shares of SMLR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:SMLR) was last updated on 5/10/2024 by MarketBeat.com Staff From Our PartnersThe Crypto 9-5 Escape PlanCrypto 101 MediaHe Is Giving Away BitcoinCrypto Swap ProfitsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingCharles Payne Demystifies OptionsUnstoppable ProsperityShocking: One AI startup's revenue could surge 4,735%Manward Press[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsMissed NVDA? Buy this AI stock NOWChaikin AnalyticsGold ManiaStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Semler Scientific, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
